Teleflex to Present at European Society for Emergency Medicine (EuSEM), in Vienna, Austria
September 30 2016 - 6:00PM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care, urology and surgery, is
committed to connecting clinicians with technology in a way that
improves clinical practice and advances patient outcomes. Teleflex
will present its innovative intraosseous vascular access system and
products for rescue airway, atomization and intubation needs at the
European Society for Emergency Medicine (EuSEM) in Vienna, Austria
on October 2-5, 2016.
The main objective of EuSEM is to help and support European
countries to implement the specialty of Emergency Medicine. Born as
a society of individuals in 1994 from a multidisciplinary group of
experts in Emergency Medicine, since 2005, EuSEM has also
incorporated national society members. There are currently 33
European national societies of Emergency Medicine.
During the event, Teleflex will showcase its Arrow® EZ-IO®
Intraosseous Vascular Access System and other products for rescue
airway, atomization and intubation needs, and support an industry
workshop on Free Open Access Medical Education (FOAM) entitled
“FOAM Rises: Is it clean air or rotten gas?”
The Arrow® EZ-IO® Intraosseous Vascular Access System from
Teleflex is an innovative and complete solution for rapid vascular
access – whether the emergency responder is facing difficult
vascular access challenges or the need for fast intraosseous access
for critical situations and life-threatening emergencies. This
system is designed to provide the medical professional vascular
access to the central circulation system within seconds1,
delivering medications, intravenous fluids and blood products to
adult and pediatric patients alike.
During EuSEM, Teleflex will also focus on the new LMA®
Protector™ Laryngeal Mask Airway. The LMA® Protector™ Airway
represents a new chapter in Teleflex’s search for the optimum
subglottic airway. With a fully silicone construction, Cuff Pilot™
Technology, dual gastric channels and the ability to intubate, the
LMA® Protector™ Airway is the most advanced second generation
airway from Teleflex.
When IV drug delivery is problematic, the LMA® MAD Nasal™
Device2 from Teleflex can come to the rescue delivering safe,
painless and rapidly effective treatment. No needle. No trauma. No
risk of needle stick injury. In addition, Teleflex will introduce a
range of laryngoscopes featuring the TruLite Secure™ Single-Use
Laryngoscope blade and handle, complementing our existing
Anaesthesia portfolio to offer complete airway solutions.
The Teleflex Clinical & Medical Affairs team will also be
supporting a lecture held by Dr. Roger Harris, a senior staff
specialist in the intensive care unit at the Royal North Shore
Hospital and the Sydney Adventist Hospital (SAN). He is dual
qualified in Emergency Medicine and Intensive Care and will present
a lecture entitled “FOAM Rises: Is it clean air or rotten gas?”
discussing the latest Free Open Access Medical Educational models
and trends. The lecture will be held on Monday, October 3, 12:55 -
13:55 in the Forum/Room D. The Teleflex Clinical & Medical
Affairs team is dedicated to ensuring the safe and appropriate use
of Teleflex products and using innovative educational programs to
advance clinical practice and improve patient outcomes.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI,
LMA, LMA Protector, MAD Nasal, Pilling, Rüsch, and Weck are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries. © 2016 Teleflex
Incorporated. All rights reserved.
References:
1Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does intraosseous
equal intravenous? A pharmacokinetic study. Amer J Emerg Med
2008;26:31-8
2For use with drugs approved for intranasal delivery
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160930005422/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Sep 2023 to Sep 2024